📰 Mitsui News
Page 13 - Mitsui News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mitsui. Real-time updates on events, politics, business and more.
April 8, 2024
The fresh delay and cost escalation are due to quality issues encountered during pre-commissioning activities.
April 8, 2024
Bringing you the latest updates on funding deals and activities in the Asia Pacific.
April 8, 2024
The Japanese government released the results of the remaining "Round 2" offshore wind auctions. A consortium of Japanese and foreign developers was selected. Meanwhile, the next "Round...
April 5, 2024
Bringing you the latest updates on funding deals and activities in the Asia Pacific.
April 5, 2024
SINGAPORE- Japan's Mitsui & Co, said on Thursday (April 4) it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million. Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86 per cent of...
April 5, 2024
SINGAPORE: Japan's Mitsui & Co said on Thursday (Apr 4) it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million (US$594 million). Mitsui said in a statement that a special purpose company jo
April 5, 2024
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International.
April 4, 2024
Tokyo stocks opened higher on Thursday after US tech shares gained in mixed Wall Street trade. The benchmark Nikkei 225 index was up 1.24 percent, or 489.25 points, at 39,941.10 in early trade, while the broader Topix index added 0.90 percent, or 24.31 points, to 2,730.82. ..
April 4, 2024
Mitsui & Co., Ltd. has decided to acquire shares in Eu Yan Sang International Ltd jointly with ROHTO Pharmaceutical Co., Ltd. and others. Based in Singapore, EYS manufactures and...
April 4, 2024
Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million ($594 million). Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86% of Eu Yan Sang from Righteous Crane Holding. Righteous Crane Holding is owned by a fund managed by Tower Capital Asia, a unit of Temasek Holdings and fo...